Unique ID issued by UMIN | UMIN000029739 |
---|---|
Receipt number | R000033767 |
Scientific Title | Impact of switching from once-weekly GLP1receptor agonist to once-weekly DPP4inhibitor(Omaligliptin)therapy on glycemic control parameters in type 2 diabetes patients undergoing hemodialysis. |
Date of disclosure of the study information | 2017/10/30 |
Last modified on | 2023/05/02 11:24:36 |
Impact of switching from once-weekly GLP1receptor agonist to once-weekly DPP4inhibitor(Omaligliptin)therapy on glycemic control parameters in type 2 diabetes patients undergoing hemodialysis.
DO study
Impact of switching from once-weekly GLP1receptor agonist to once-weekly DPP4inhibitor(Omaligliptin)therapy on glycemic control parameters in type 2 diabetes patients undergoing hemodialysis.
DO study
Japan |
Type 2 daiabetes
Chronic renal failure
Medicine in general | Endocrinology and Metabolism | Nephrology |
Others
NO
There is few reports that estimate impact of switching from once-weekly GLP1 receptor agonist to once-weekly DPP4 inhibitor(Omaligliptin) therapy on glycemic control parameters in type 2 diabetes patients undergoing hemodialysis.We estimate blood glucose level by continuous glucose monitoring(CGM).
Bio-equivalence
Glucose estimated by CGM
GA,height,weight,BP,HR,WBC,RBC,Hb,Ht,PLT,TG,HDL-CHO,LDL-CHO,AST,ALT,gamma-GTP,BUN,UA,CRN,Na,K,Cl
Interventional
Single arm
Non-randomized
Open -no one is blinded
Uncontrolled
NO
1
Treatment
Medicine |
Dulaglutide(0.75mg)/week for 3 weeks more then switch to Omarigliptin for 4 weeks
20 | years-old | <= |
Not applicable |
Male and Female
1.Under 10.0% HbA1c for last 3 months or more
2.Agreement for the use of data
3.Under hemodialysis for 6 mouths or more
1.Using other GLP1 analog formulation
2.Using other DPP4 inhibitor
3.Hypersensitivity for Dulaglutide and Omarigliptin
4.Severe ketosis,Diabetic coma and pre-coma,type 1 diabetes
5.Severe infection,pre and post operation ,severe trauma,such state with necessity of blood suger management by Insulin treatment
6.Pregnant woman,woman suspected of being pregnant,woman in breast-feeding
7.Patiants recognized to be inappropriate for study by medical basis of doctor
10
1st name | Yasurou |
Middle name | |
Last name | Kumeda |
Minamiosaka hospital
Department of internal medicine
559-0012
1-18-18 Higashikagaya Suminoe-ku Osaka city Osaka Japan
06-6685-0221
snorikoho2@gmail.com
1st name | Noriko |
Middle name | |
Last name | Sakuma |
Minamiosaka hospital
Department of internal medicine
559-0012
1-18-18 Higashikagaya Suminoe-ku Osaka city Osaka Japan
06-6685-0221
snorikoho2@gmail.com
Minamiosaka hospital
Self funding
Self funding
Minamiosaka hospital
1-18-18Higashikagaya Sumioeku Osaka city Osaka Japan
06-6885-0221
snorikoh02@gmail.com
NO
2017 | Year | 10 | Month | 30 | Day |
No implementation
Unpublished
No implementation
0
No implementation
2023 | Year | 05 | Month | 02 | Day |
No implementation
No implementation
No implementation
No implementation
Terminated
2017 | Year | 10 | Month | 14 | Day |
2017 | Year | 10 | Month | 14 | Day |
2017 | Year | 10 | Month | 30 | Day |
2018 | Year | 10 | Month | 30 | Day |
2017 | Year | 10 | Month | 27 | Day |
2023 | Year | 05 | Month | 02 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000033767
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |